Top Markets
Coin of the day
Stryker Corporation Stryker Corporation

Stryker Corporation

SYK
Rang in Aktien #160
Stryker Corporation operates as a medical technology company. The company... Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Aktienkurs
$336.84
Marktkapitalisierung
$129.13B
Veränderung (1 Tag)
2.00%
Veränderung (1 Jahr)
-15.94%
Land
US
Handel Stryker Corporation (SYK)

Kategorie

Gewinn für Stryker Corporation (SYK)
Gewinn im Mar 2026 TTM: $4.60B
Laut den aktuellen Finanzberichten von Stryker Corporation betragen die aktuellen Gewinne des Unternehmens $4.60B. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $3.49B, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2023, der $3.67B betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Stryker Corporation von 2000 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $4.60B 1.91%
2025 $4.51B 29.27%
2024 $3.49B -4.93%
2023 $3.67B 36.90%
2022 $2.68B 17.62%
2021 $2.28B 16.73%
2020 $1.95B -23.73%
2019 $2.56B 8.74%
2018 $2.36B 14.20%
2017 $2.06B 7.39%
2016 $1.92B 10.72%
2015 $1.74B 49.57%
2014 $1.16B -4.29%
2013 $1.21B -28.91%
2012 $1.71B 1.13%
2011 $1.69B -2.52%
2010 $1.73B 6.51%
2009 $1.62B 2.77%
2008 $1.58B 15.33%
2007 $1.37B 24.13%
2006 $1.10B 10.02%
2005 $1.00B 39.93%
2004 $717.00M 9.89%
2003 $652.50M 28.77%
2002 $506.70M 24.90%
2001 $405.70M 21.14%
2000 $334.90M 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$7.51B 63.28%
US
$6.14B 33.42%
IE
$3.74B -18.65%
US
$1.30B -71.78%
US
$1.20B -73.83%
US